share_log

NRX Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-CHIEF FINANCIAL OFFICER VAN VOORHEES SETH

NRX Pharmaceuticals | 4/A:持股变动声明(修正)-首席财务官 VAN VOORHEES SETH

美股sec公告 ·  2022/12/19 07:08
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息